You must log in to view this page.

Outlook Therapeutics Inc. – Filings and Transcripts

NASDAQ: OTLK
Share price (9/21/26): $0.69
Market cap (9/21/26): $167 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q3

Late quarterly filing notification for Q3 2026

ended 03/31/26 Q2

ended 12/31/25 Q1

ended 09/30/25 FY 2025

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement

Shelf registration

Draft registration statement

Ownership Filter

Lundquist Kevin Michael

Lundquist Kevin Michael

CVI Investments, Inc.

Kenyon Lawrence A

Jahr Robert Charles

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Other Events, Financial Statements or Exhibits

Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Summary of Select Risks

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC